CG Oncology, Inc. (CGON) Shareholders’ equity 2023–2025
CG Oncology, Inc. (CGON) shareholders’ equity at each fiscal year-end, per SEC filings.
$752.6MFY2025 · since FY2023: -$123.1M → $752.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $752.6M | +2.6% |
| FY2024 | $733.4M | +695.8% |
| FY2023 | -$123.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice